Research graph
References from Impact of Human Papillomavirus Primary Cervical Screening on Referral Rates and Outcomes for People Referred to Colposcopy for Clinical Reasons. Local targets link to admitted publications; unresolved targets remain external evidence.
The Diagnostic Accuracy of Colposcopy – A Review of Research Methodology and Impact on the Outcomes of Quality Assurance
10.1016/j.ejogrb.2019.07.003 · 2019 · External reference
Unresolved reference
2023 · External reference
The Frequency of Significant Pathology in Women Attending a General Gynaecological Service for Postcoital Bleeding
2001 · External reference
Benefits and Potential Harms of Human Papillomavirus (HPV)‐Based Cervical Cancer Screening: A Real‐World Comparison of HPV Testing Versus Cytology
10.1111/aogs.14121 · 2021 · External reference
Unresolved reference
2025 · External reference
10.1007/978-3-031-56806-0_34
10.1007/978-3-031-56806-0_34 · 2024 · External reference
ASCCP Colposcopy Standards: Role of Colposcopy, Benefits, Potential Harms, and Terminology for Colposcopic Practice
10.1097/lgt.0000000000000338 · 2017 · External reference
Unresolved reference
2024 · External reference
Widening the Offer of Human Papillomavirus Self‐Sampling to All Women Eligible for Cervical Screening: Make Haste Slowly
10.1002/ijc.34358 · 2023 · External reference
The IARC Perspective on Cervical Cancer Screening
10.1056/nejmsr2030640 · 2021 · External reference
Identifying Barriers to Treatment for Women With Cervical Dysplasia in Rural Northern British Columbia
10.1016/j.jogc.2018.02.009 · 2018 · External reference
Quantifying Unmet Secondary Healthcare Need in New Zealand: A Multi‐Year Population Study Using Administrative Data
10.1136/bmjopen-2025-099726 · 2025 · External reference
Implementation of Australia's Renewed Cervical Screening Program: Preparedness of General Practitioners and Nurses
10.1371/journal.pone.0228042 · 2020 · External reference
Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High‐Grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial
10.1001/jama.2018.7464 · 2018 · External reference
Assessing 10‐Year Safety of a Single Negative HPV Test for Cervical Cancer Screening: Evidence From FOCAL‐DECADE Cohort
10.1158/1055-9965.epi-20-1177 · 2021 · External reference
Vulvar Inspection at the Time of Cervical Cancer Screening: European Society of Gynaecological Oncology (ESGO), International Society for the Study of Vulvovaginal Disease (ISSVD), European College for the Study of Vulval Disease (ECSVD), and European Federation for Colposcopy (EFC) Consensus Statements
10.1016/j.ijgc.2024.100007 · 2025 · External reference
Human Papillomavirus‐Negative Cervical Cancer: A Comprehensive Review
10.3389/fonc.2020.606335 · 2020 · External reference
Cervical Cancer Screening: A Review
10.1001/jama.2023.13174 · 2023 · External reference
Unresolved reference
2021 · External reference
